A new CSP position was established today on Valeant Pharmaceuticals (VRX). All prices include IB commissions.
This non-Dividend Champion position meets the minimum requirement of 12% Downside Protection and 12% Annualized Return.
| Criteria | Value |
|---|---|
| Downside Protection | 12.88% |
| Annualized Return | 12.89% |
| Fair Value Estimate | $75.00 |
| Target Buy Price | $45.00 |
| Target Margin of Safety | 40.00% |
| Actual Buy Price | $57.50 |
| Actual Margin of Safety | 23.33% |
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|---|---|---|---|---|---|
| 1/25/2013 | VRX | CSP Margin Used | CSP 100 VRX @ 57.50 | ($5,750.00) | ||
| 1/25/2013 | VRX | Initial Put Option | STO 1 Mar13 57.50 Put @ 1.00 | $99.51 |
Position Summary
| Cost Basis | ($5,750.00) |
| Income Generated | $99.51 |
| Percent Income Generated | 1.73% |
| Annualized Income Generated | 12.89% |
| Net Profit If Closed | $99.51 |
| Percent Return If Closed | 1.73% |
| Annualized Return If Closed | 12.89% |
| Days Held to Expiration | 49 days |
